This company listing is no longer active
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Master Pharm Résultats passés
Passé contrôle des critères 0/6
Informations clés
-21.5%
Taux de croissance des bénéfices
-18.8%
Taux de croissance du BPA
| Personal Products Croissance de l'industrie | 36.3% |
| Taux de croissance des recettes | 3.4% |
| Rendement des fonds propres | 2.0% |
| Marge nette | 2.1% |
| Prochaine mise à jour des résultats | 17 Nov 2022 |
Mises à jour récentes des performances passées
Recent updates
Calculating The Intrinsic Value Of Master Pharm SA (WSE:MPH)
Feb 05
Returns On Capital At Master Pharm (WSE:MPH) Have Hit The Brakes
Dec 13A Look At The Intrinsic Value Of Master Pharm SA (WSE:MPH)
May 25Master Pharm (WSE:MPH) Will Will Want To Turn Around Its Return Trends
Mar 30Is Master Pharm SA's (WSE:MPH) Latest Stock Performance Being Led By Its Strong Fundamentals?
Mar 02I Ran A Stock Scan For Earnings Growth And Master Pharm (WSE:MPH) Passed With Ease
Feb 04
Master Pharm (WSE:MPH) Is Growing Earnings But Are They A Good Guide?
Jan 08Here's What To Make Of Master Pharm's (WSE:MPH) Returns On Capital
Dec 18Master Pharm SA (WSE:MPH) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Nov 27Ventilation des recettes et des dépenses
Comment Master Pharm gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Jun 22 | 79 | 2 | 24 | 0 |
| 31 Mar 22 | 73 | 4 | 1 | 0 |
| 31 Dec 21 | 77 | 4 | 22 | 0 |
| 30 Sep 21 | 72 | -3 | 21 | 0 |
| 30 Jun 21 | 75 | 2 | 21 | 0 |
| 31 Mar 21 | 69 | 1 | 20 | 0 |
| 31 Dec 20 | 61 | 0 | 20 | 0 |
| 30 Sep 20 | 63 | 12 | 22 | 0 |
| 30 Jun 20 | 68 | 13 | 22 | 0 |
| 31 Mar 20 | 71 | 12 | 24 | 0 |
| 31 Dec 19 | 71 | 13 | 24 | 0 |
| 30 Sep 19 | 73 | 9 | 26 | 0 |
| 30 Jun 19 | 74 | 9 | 27 | 0 |
| 31 Mar 19 | 72 | 9 | 27 | 0 |
| 31 Dec 18 | 75 | 11 | 27 | 0 |
| 30 Sep 18 | 75 | 11 | 26 | 0 |
| 30 Jun 18 | 70 | 10 | 26 | 0 |
| 31 Mar 18 | 68 | 9 | 24 | 0 |
| 31 Dec 17 | 64 | 8 | 24 | 0 |
| 30 Sep 17 | 57 | 7 | 23 | 0 |
| 30 Jun 17 | 52 | 6 | 21 | 0 |
| 31 Mar 17 | 51 | 8 | 21 | 0 |
| 31 Dec 16 | 49 | 7 | 19 | 0 |
| 30 Sep 16 | 50 | 8 | 19 | 0 |
| 30 Jun 16 | 53 | 7 | 19 | 0 |
| 31 Mar 16 | 53 | 9 | 18 | 0 |
| 31 Dec 15 | 49 | 8 | 16 | 0 |
| 30 Sep 15 | 43 | 8 | 13 | 0 |
Des revenus de qualité: MPH has a large one-off loss of PLN7.4M impacting its June 30 2022 financial results.
Augmentation de la marge bénéficiaire: MPH's current net profit margins (2.1%) are lower than last year (2.8%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: MPH's earnings have declined by 21.5% per year over the past 5 years.
Accélération de la croissance: MPH's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Bénéfices par rapport au secteur d'activité: MPH had negative earnings growth (-18.7%) over the past year, making it difficult to compare to the Personal Products industry average (8.9%).
Rendement des fonds propres
ROE élevé: MPH's Return on Equity (2%) is considered low.